Oral L-Arg and D-Arg increased arginase protein expression in the liver, but L-Arg decreased it in the upper small intestine (Sm. Intes.), whereas L-Arg decreased arginase activity... by Dain (Raina) Kim (16726470)

Oral L-Arg and D-Arg increased arginine decarboxylase protein expression in the liver, but decreased it in the upper small intestine (Sm. Intes.); whereas D-Arg increased agmatinas... by Dain (Raina) Kim (16726470)

Pre-treatment of OJS did not mitigate DRG activation but decreased inflammatory responses in BMDM. by Patrice Cunningham (12914917)

FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

“…<p>(A) HuH6 cells (2.5 x 10⁶ cells in 25% Matrigel) were injected subcutaneously into the right flank of 6-week-old female athymic nude mice. …”

Oral L-Arg and D-Arg decreased arginine:glycine amidinotransferase protein expression in the liver, but L-Arg increased it in the kidney. by Dain (Raina) Kim (16726470)

Rab27A deficiency caused decreased amylase release from isolated acini. by Yanan Hou (736195)

PV1-treated mice exhibited a decrease in overall activation of T lymphocytes. by Pedro Henrique Papotto (791904)

Pretreatment with ATZ decreased the level of phosphorylated JNK in APAP exposed mice. by Yuping Jing (725667)

Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro. by David A. Davis (239142)

“…(D) Tubulin monomers were incubated in the presence of 0.05 mg/ml tau only or together with 10 µM of GST-Capzb2 or 10 µM of GST-tag. …”

Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

Pretreatment with ATZ decreased the level of CYP2E1 in APAP exposed mice. by Yuping Jing (725667)

Combined therapeutic treatment with 2ME2 and SD-208 additively decreases bone metastases in mice. by Lauren K. Dunn (260121)

Administration of γPGA attenuates Th2 immune responses elicited by the cysteine protease papain through a decrease in basophils. by Hyun Jung Park (116737)

Pioglitazone Decreases Hepatitis C Viral Load in Overweight, Treatment Naïve, Genotype 4 Infected-Patients: A Pilot Study by Mario Chojkier (82942)

“…Pioglitazone was effective in decreasing serum HCV RNA at day-14 (n = 10; difference of means = 205,618 IU/ml; 95% CI 26,600 to 384,600; <em>P</em><0.001). …”

H₂ water decreased the accumulation of 8-oxoG in striatum after MPTP administration. by Kyota Fujita (258978)

Treatment of Balb/c mice with P28GST after TNBS induction of colitis decreases intestinal inflammation. by Aurore Sarazin (6162698)

Mean liver weight (g) (A), liver weight/body ratio (B), hepatic triglyceride (mg/g) (C) and hepatic steatosis quantification (% area) (D) upon completion of the treatment phase. by Elsie D. Oduor (22521785)

Supplementary Material for: Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (... by figshare admin karger (2628495)

Changes in IL-6 levels during uric acid or rasburicase infusion and oral lipid tolerance test pre- and post- intervention. by Toshiko Tanaka (174638)

Changes in uric acid levels during uric acid or rasburicase administration. by Toshiko Tanaka (174638)